1984
|
Sign up to set email alerts
Betaxolol and Timolol
Search citation statements
Order By: Relevance
Paper Sections
Select...
98
1
1
0
Citation Types
0
4
0
0
Year Published
Range
1984
19842025
2025Publication Types
Select...
79
19
1
Relationship
0
99
Authors
Journals
Cited by 99 publications
(4 citation statements)
References 11 publications
0
4
0
0
Order By: Relevance
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Notably, several undesirable ocular effects are shared across different drug classes. Discomfort upon instillation, including symptoms such as stinging, burning, itching, tearing, and blurred vision, are frequently reported with all classes of glaucoma medications [10,16,[60][61][62][63][64][65][66][76][77][78]83,[89][90][91][92][93][94][95][96][97][98]. Additionally, ocular allergic reactions, which may necessitate discontinuation in severe cases, commonly present as allergic conjunctivitis, granulomatous papillary conjunctivitis, or punctate keratopathy.…”
Section: Discussion
mentioning
confidence: 99%
“…Rarely: hyperemia, corneal decompensation, and contact dermatitis Oral: Symptom complex (47.8%): general malaise, weight loss, fatigue, nausea, anorexia, depression and loss of libido [130]. Organs involved: gastrointestinal, neurological, and hematological Topical: transient bitter or metallic taste (25%) [16,54,55,139]; Rarely: nausea, fatigue, headache, skin rashes, paresthesia, and urolithiasis Βeta (β) blockers -Burning or stinging sensation on instillation (~30-40% of patients), eye pain or discomfort, foreign body sensation, itchiness, and blurred vision (due to membrane stabilization property & formulation) [10,[60][61][62][63][64][65][66].…”
Section: Drug Class
mentioning
confidence: 99%
“…Subjective side effects may include burning or stinging sensation on instillation (in up to 30-40% of patients), eye pain or discomfort, foreign body sensation, itchiness, and blurred vision [10,[60][61][62][63][64][65][66].…”
Section: βEta (β) Blockers
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Notably, several undesirable ocular effects are shared across different drug classes. Discomfort upon instillation, including symptoms such as stinging, burning, itching, tearing, and blurred vision, are frequently reported with all classes of glaucoma medications [10,16,[60][61][62][63][64][65][66][76][77][78]83,[89][90][91][92][93][94][95][96][97][98]. Additionally, ocular allergic reactions, which may necessitate discontinuation in severe cases, commonly present as allergic conjunctivitis, granulomatous papillary conjunctivitis, or punctate keratopathy.…”
Section: Discussion
mentioning
confidence: 99%
“…Rarely: hyperemia, corneal decompensation, and contact dermatitis Oral: Symptom complex (47.8%): general malaise, weight loss, fatigue, nausea, anorexia, depression and loss of libido [130]. Organs involved: gastrointestinal, neurological, and hematological Topical: transient bitter or metallic taste (25%) [16,54,55,139]; Rarely: nausea, fatigue, headache, skin rashes, paresthesia, and urolithiasis Βeta (β) blockers -Burning or stinging sensation on instillation (~30-40% of patients), eye pain or discomfort, foreign body sensation, itchiness, and blurred vision (due to membrane stabilization property & formulation) [10,[60][61][62][63][64][65][66].…”
Section: Drug Class
mentioning
confidence: 99%
“…Subjective side effects may include burning or stinging sensation on instillation (in up to 30-40% of patients), eye pain or discomfort, foreign body sensation, itchiness, and blurred vision [10,[60][61][62][63][64][65][66].…”
Section: βEta (β) Blockers
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Betaxolol hydrochloride is a cardioselective betaadrenergic receptor blocking agent used in the treatment of hypertension and glaucoma 1–4. Betaxolol hydrochloride was approved by the US Food and Drug Administration (FDA) for the treatment of hypertension as 10 mg and 20 mg tablets for oral administration.…”
Section: Introduction
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Notably, several undesirable ocular effects are shared across different drug classes. Discomfort upon instillation, including symptoms such as stinging, burning, itching, tearing, and blurred vision, are frequently reported with all classes of glaucoma medications [10,16,[60][61][62][63][64][65][66][76][77][78]83,[89][90][91][92][93][94][95][96][97][98]. Additionally, ocular allergic reactions, which may necessitate discontinuation in severe cases, commonly present as allergic conjunctivitis, granulomatous papillary conjunctivitis, or punctate keratopathy.…”
Section: Discussion
mentioning
confidence: 99%
“…Rarely: hyperemia, corneal decompensation, and contact dermatitis Oral: Symptom complex (47.8%): general malaise, weight loss, fatigue, nausea, anorexia, depression and loss of libido [130]. Organs involved: gastrointestinal, neurological, and hematological Topical: transient bitter or metallic taste (25%) [16,54,55,139]; Rarely: nausea, fatigue, headache, skin rashes, paresthesia, and urolithiasis Βeta (β) blockers -Burning or stinging sensation on instillation (~30-40% of patients), eye pain or discomfort, foreign body sensation, itchiness, and blurred vision (due to membrane stabilization property & formulation) [10,[60][61][62][63][64][65][66].…”
Section: Drug Class
mentioning
confidence: 99%
“…Subjective side effects may include burning or stinging sensation on instillation (in up to 30-40% of patients), eye pain or discomfort, foreign body sensation, itchiness, and blurred vision [10,[60][61][62][63][64][65][66].…”
Section: βEta (β) Blockers
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Betaxolol hydrochloride is a cardioselective betaadrenergic receptor blocking agent used in the treatment of hypertension and glaucoma 1–4. Betaxolol hydrochloride was approved by the US Food and Drug Administration (FDA) for the treatment of hypertension as 10 mg and 20 mg tablets for oral administration.…”
Section: Introduction
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Notably, several undesirable ocular effects are shared across different drug classes. Discomfort upon instillation, including symptoms such as stinging, burning, itching, tearing, and blurred vision, are frequently reported with all classes of glaucoma medications [10,16,[60][61][62][63][64][65][66][76][77][78]83,[89][90][91][92][93][94][95][96][97][98]. Additionally, ocular allergic reactions, which may necessitate discontinuation in severe cases, commonly present as allergic conjunctivitis, granulomatous papillary conjunctivitis, or punctate keratopathy.…”
Section: Discussion
mentioning
confidence: 99%
“…Rarely: hyperemia, corneal decompensation, and contact dermatitis Oral: Symptom complex (47.8%): general malaise, weight loss, fatigue, nausea, anorexia, depression and loss of libido [130]. Organs involved: gastrointestinal, neurological, and hematological Topical: transient bitter or metallic taste (25%) [16,54,55,139]; Rarely: nausea, fatigue, headache, skin rashes, paresthesia, and urolithiasis Βeta (β) blockers -Burning or stinging sensation on instillation (~30-40% of patients), eye pain or discomfort, foreign body sensation, itchiness, and blurred vision (due to membrane stabilization property & formulation) [10,[60][61][62][63][64][65][66].…”
Section: Drug Class
mentioning
confidence: 99%
“…Subjective side effects may include burning or stinging sensation on instillation (in up to 30-40% of patients), eye pain or discomfort, foreign body sensation, itchiness, and blurred vision [10,[60][61][62][63][64][65][66].…”
Section: βEta (β) Blockers
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Betaxolol hydrochloride is a cardioselective betaadrenergic receptor blocking agent used in the treatment of hypertension and glaucoma 1–4. Betaxolol hydrochloride was approved by the US Food and Drug Administration (FDA) for the treatment of hypertension as 10 mg and 20 mg tablets for oral administration.…”
Section: Introduction
mentioning
confidence: 99%